Skip to main content

Table 7 Predictivity of clinical response by different biomarkers or in vitro chemosensitivity test

From: Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy

  Sensitivity (%) Resistance (%) p
Markers    
   MGMT 75.0 72.5 0.03
   XPD 37.5 90.9 0.06
   Five markers 33.3 100 0.07
Chemosensitivity test 85.7 91.3 0.0003